Your browser doesn't support javascript.
loading
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.
Scolyer, Richard A; Atkinson, Victoria; Gyorki, David E; Lambie, Duncan; O'Toole, Sandra; Saw, Robyn P M; Amanuel, Benhur; Angel, Christopher M; Button-Sloan, Alison E; Carlino, Matteo S; Ch'ng, Sydney; Colebatch, Andrew J; Daneshvar, Dariush; Pires da Silva, Inês; Dawson, Tamara; Ferguson, Peter M; Foster-Smith, Erwin; Fox, Stephen B; Gill, Anthony J; Gupta, Ruta; Henderson, Michael A; Hong, Angela M; Howle, Julie R; Jackett, Louise A; James, Craig; Lee, C Soon; Lochhead, Alistair; Loh, Daphne; McArthur, Grant A; McLean, Catriona A; Menzies, Alexander M; Nieweg, Omgo E; O'Brien, Blake H; Pennington, Thomas E; Potter, Alison J; Prakash, Saurabh; Rawson, Robert V; Read, Rebecca L; Rtshiladze, Michael A; Shannon, Kerwin F; Smithers, B Mark; Spillane, Andrew J; Stretch, Jonathan R; Thompson, John F; Tucker, Paul; Varey, Alexander H R; Vilain, Ricardo E; Wood, Benjamin A; Long, Georgina V.
Afiliación
  • Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfre
  • Atkinson V; Princess Alexandra Hospital & Greenslopes Private Hospital, Brisbane, Qld, Australia; Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Qld, Australia; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.
  • Gyorki DE; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia.
  • Lambie D; Anatomical Pathology, Princess Alexandra Hospital, Pathology Queensland, Brisbane, Qld, Australia; University of Queensland Diamantina Institute, Brisbane, Qld, Australia.
  • O'Toole S; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia.
  • Amanuel B; School of Medical and Health Sciences, Edith Cowan University, WA, Australia; PathWest Laboratory Medicine WA, Nedlands, WA, Australia.
  • Angel CM; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Button-Sloan AE; Australia Melanoma Consumer Alliance, Melbourne, Vic, Australia.
  • Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia.
  • Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Colebatch AJ; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Daneshvar D; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Pathology West, Tissue Pathology & Diagnostic Oncology, ICPMR-Westmead, Sydney, NSW, Australia.
  • Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Sydney, NSW, Australia.
  • Dawson T; Melanoma & Skin Cancer Advocacy Network, Melbourne, Vic, Australia.
  • Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Foster-Smith E; SA Pathology, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Fox SB; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; University of Melbourne, Melbourne, Vic, Australia.
  • Gill AJ; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Gupta R; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Henderson MA; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia.
  • Hong AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia.
  • Howle JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia.
  • Jackett LA; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Austin Pathology, Melbourne, Vic, Australia.
  • James C; Clinpath Pathology, Mile End, Adelaide, SA, Australia.
  • Lee CS; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; School of Medicine, Western Sydney University, Campbelltown, Sydney, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, Sydney, NSW, Australi
  • Lochhead A; Southern.IML Pathology, Coniston, NSW, Australia; The Wollongong Hospital, Wollongong, NSW, Australia; University of Wollongong, Wollongong, NSW, Australia.
  • Loh D; ACT Pathology, Canberra Hospital, Canberra, ACT, Australia.
  • McArthur GA; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia.
  • McLean CA; Anatomical Pathology Department, Alfred Hospital, Melbourne, Vic, Australia; Department of Medicine Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia.
  • Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • O'Brien BH; Sullivan Nicolaides Pathology, Brisbane, Qld, Australia.
  • Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Potter AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Prakash S; Melbourne Pathology (Sonic Healthcare), Melbourne, Vic, Australia.
  • Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Read RL; Calvary Health Care, Canberra, ACT, Australia; College of Health and Medicine, Australian National University, Canberra, ACT, Australia.
  • Rtshiladze MA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia.
  • Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Smithers BM; Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Qld, Australia; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.
  • Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia.
  • Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Tucker P; Hobart Pathology, Hobart, Tas, Australia.
  • Varey AHR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia.
  • Vilain RE; NSW Health Pathology, Sydney, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; John Hunter Hospital, Newcastle, NSW, Australia.
  • Wood BA; PathWest Laboratory Medicine WA, Nedlands, WA, Australia; The University of Western Australia, Perth, WA, Australia.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore
Pathology ; 54(1): 6-19, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34937664
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Melanoma Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Pathology Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Melanoma Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Pathology Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido